U.S. FDA
Ask about this →0 mentions · last seen 6/5/2026
The Encyclopædia of Indian Retail — revised every hour
0 mentions · last seen 6/5/2026
After a January inspection, the U.S. drug regulator cited Dabur India for falsified records, microbial contamination risks, poor maintenance and even a live bird in the raw material warehouse at its Dadra and Nagar Haveli facility, raising compliance concerns for the 140-year-old FMCG major.
ET Retail · 5/29/2026, 7:40:43 AM
The U.S. drug regulator cited Dabur India's Dadra and Nagar Haveli facility for falsified records, a live bird in the raw materials warehouse, and unreliable microbiology testing. The findings raise export-quality concerns for the 140-year-old FMCG major's U.S. health portfolio.
ET Small Business · 5/29/2026, 7:16:56 AM